
Senseonics Holdings (SENS) Stock Forecast & Price Target
Senseonics Holdings (SENS) Analyst Ratings
Bulls say
Senseonics Holdings is strengthening its fundamental case through explosive U.S. commercialization, with 3Q revenue of $19.6 million up 140% year over year and gross margin near 62%, while active prescribers rose more than 90% and record new patient starts showed the Eversense 365 launch is gaining real traction. The company’s outlook is further supported by a widening recurring base, as management expects about $40-50 million of 2027 revenue from reorders, while DTC demand, Eon Care’s more than 100 inserters, and pump-integration opportunities expand the addressable funnel. With $126.6 million in cash, raised 2026 revenue guidance of $68-70 million, and a differentiated long-wear implantable platform moving toward Freedom and Gemini milestones, Senseonics Holdings is positioned to sustain growth while advancing toward higher-margin, longer-term innovation.
Bears say
Senseonics Holdings is challenged by persistent operating losses since inception and continuing uncertainty around achieving sustained profitability, which raises going-concern concerns and leaves liquidity dependent on future capital or materially improved execution. Its outlook is further pressured by heavy reliance on Ascensia’s commercialization efforts, where any sales, marketing, or execution shortfalls could directly weaken revenue growth, while quarterly and annual volatility may intensify investor uncertainty. The investment case is also constrained by fierce competition from Abbott, DexCom, MiniMed, and GLP-1 therapies, alongside regulatory, reimbursement, and product-development risks tied to Gemini and Freedom, all of which threaten Eversense’s market share and cash runway.
This aggregate rating is based on analysts' research of Senseonics Holdings and is not a guaranteed prediction by Public.com or investment advice.
Senseonics Holdings (SENS) Analyst Forecast & Price Prediction
Start investing in Senseonics Holdings (SENS)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Senseonics Holdings (SENS) Forecast
Senseonics Holdings (SENS) Analyst Forecast & Price Prediction
Start investing in Senseonics Holdings (SENS)
Order type
Buy in
Order amount
Est. shares
0 shares